We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Method Introduced for Dry Storage of Biological Samples

By LabMedica International staff writers
Posted on 12 Mar 2018
A novel method for preserving biological samples collected for diagnostic testing at room temperature may one day eliminate the need for refrigeration, which is often not available in third-world settings.

Investigators at Washington University (St. More...
Louis, MO, USA) have introduced a universal biospecimen preservation approach based on nanoporous material encapsulation for preserving protein biomarkers in biofluids under normal (nonrefrigerated) storage conditions. The protein biomarkers in the relevant biofluids such as blood, urine, serum, and plasma are first encapsulated within nanoporous zeolitic imidazolate framework-8 (ZIF-8) crystals and then dried on paper substrates via a dry spot sample collection method. Zeolitic imidazolate frameworks (ZIFs) are a class of metal-organic frameworks composed of tetrahedrally coordinated transition metal ions (e.g. Fe, Co, Cu, Zn) connected by imidazolate linkers.

To test the dry storage method, the investigators used artificial urine samples spiked with neutrophil gelatinase-associated lipcalin (NGAL), a biomarker for acute kidney injury; and blood samples spiked with CA-125, a biomarker for ovarian cancer. The samples were mixed with precursors of the nanoporous material ZIF-8 and then dried on paper at room temperature.

Results revealed that urine samples stored dry at room temperature retained more than 90% of NGAL. Control samples without ZIF-8 encapsulation had less than 30% of NGAL preserved. Blood samples spiked with CA-125 and encapsulated by ZIF-8 showed about 85% preservation, while those without the encapsulation showed 50% or less preservation. Overall, results obtained with samples stored dry at temperatures up to 40 degrees Celsius showed preservation efficacy comparable to those maintained by the refrigeration method (freezing liquid samples at −20 degrees Celsius).

"One of our next steps is to take the technology out of the laboratory and commercialize it so that it can work to the greatest good for the greatest number of people," said contributing author Dr. Evan D. Kharasch, professor of biochemistry and molecular biophysics at Washington University. "This would make it widely available in both first-world countries as well as emerging countries and in emergency situations or environmental disasters where we need to deploy people and have scarce resources."

The dry storage protocol was described in detail in the February 1, 2018, online edition of the journal Chemistry of Materials.

Related Links:
Washington University


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.